Description
Buy Selank peptide 10mg per vial a synthetic heptapeptide developed as an analog of the endogenous immunomodulatory peptide tuftsin.
Buy Selank peptide 10mg per vial
- Peptide type: Synthetic heptapeptide
- Form: Lyophilized powder
- Pharmacological Category: Anxiolytic peptide
Mechanism of Action
Selank does not act as a classical benzodiazepine. Its mechanism is multifactorial:
GABAergic Modulation
- Indirect modulation of GABAergic neurotransmission.
- Enhances GABA receptor signaling without direct receptor agonism.
Serotonin and Dopamine Regulation
- Influences monoamine turnover.
- May normalize serotonin metabolism in stress models.
BDNF Expression
- Evidence suggests increased brain-derived neurotrophic factor (BDNF) expression.
Enkephalinase Inhibition
- May inhibit degradation of endogenous enkephalins.
Immunomodulation
- Derived from tuftsin, it retains mild immune-regulatory properties.
Physical Properties (Buy Selank 10 mg)
| Property | Typical Specification |
|---|---|
| Appearance | White to off-white powder |
| Solubility | Freely soluble in water |
| pH (reconstituted) | 5.0 – 7.5 |
| Stability | Stable when refrigerated |
| Hygroscopicity | Slightly hygroscopic |
| Storage | 2–8°C short term; −20°C long term |
| Reconstitution | Sterile water or bacteriostatic water |
Typical Research-Grade Specifications
| Test Parameter | Specification | Method |
|---|---|---|
| Peptide Purity | ≥ 99.0% | HPLC |
| Identity | Conforms | LC-MS |
| Molecular Weight | 751.9 ± 1 Da | Mass Spectrometry |
| Water Content | ≤ 5.0% | Karl Fischer |
| Acetic Acid Content | ≤ 10% (if acetate salt) | HPLC |
| Residual Solvents | Within ICH limits | GC |
| Related Peptide Impurities | ≤ 1.0% | HPLC |
| Endotoxins* | ≤ 0.5 EU/mg | LAL |
Selank – Half-Life and Effects
Selank is a short peptide and, like most small peptides, is subject to rapid enzymatic degradation.
Onset and Duration (Intranasal Use)
| Parameter | Approximate Timing |
|---|---|
| Onset | 10–30 minutes |
| Peak Effects | 1–2 hours |
| Duration | 4–8 hours |
Reported Effects (Based on Clinical and Preclinical Studies)
A. Anxiolytic Effects
- Reduction in generalized anxiety symptoms
- Decreased stress-induced behavioral responses
- Non-sedative calming effect
- Does not typically impair psychomotor function
Unlike benzodiazepines, Selank does not strongly bind directly to GABA-A receptors and does not produce significant sedation or dependency patterns in available studies.
B. Cognitive Effects
- Improved attention and mental clarity
- Possible enhancement of working memory
- Increased stress resilience
C. Neurochemical Effects
- Modulation of GABAergic transmission
- Influence on serotonin and dopamine turnover
- Possible increase in BDNF expression
D. Immunomodulatory Effects
- Mild immune-regulating properties (derived from tuftsin origin)
- Modulates cytokine expression in some models
Side Effect Profile of Selank 10mg
Selank has generally shown a favorable tolerability profile in studies:
- Mild nasal irritation (intranasal use)
- Headache (rare)
- Transient fatigue (uncommon)
No strong evidence of:
- Sedation
- Respiratory depression
- Withdrawal syndrome
Packaging & Export Compliance
Packaging conforms to international chemical export transport standards including:
- Aluminum moisture-barrier packaging
- Tamper-evident sealing
- Anti-static protective containment
Shipping compliance aligns with regulations from the International Air Transport Association for air freight and International Maritime Organization for sea freight.
This product is intended for laboratory research, analytical reference, or industrial testing purposes only, subject to the import and chemical control laws of the destination country.
Reviews
There are no reviews yet.